| Date Filed | Type | Description |
| 08/09/2023 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 10,000 shares
@ $2.3794, valued at
$23.8k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 600,000 shares
@ $0 |
|
| 11/16/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 20,000 shares
@ $2.2832, valued at
$45.7k
|
|
| 11/12/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Bought 200,000 shares
@ $2.0788, valued at
$415.8k
|
|
| 10/05/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 197,231 shares
@ $0
Granted 410,833 shares
@ $0
Granted 13,430 shares
@ $0
Granted 668,065 options to buy
@ $1.55, valued at
$1M
Granted 69,822 options to buy
@ $1.55, valued at
$108.2k
Granted 98,252 options to buy
@ $5.93, valued at
$582.6k
Granted 200,000 options to buy
@ $13.88, valued at
$2.8M
Granted 400,000 options to buy
@ $5.08, valued at
$2M
|
|
| 10/05/2021 |
4
| Edick Paul R (CEO) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 197,231 shares
@ $0
Disposed/sold 410,833 shares
@ $0
Disposed/sold 13,430 shares
@ $0
Disposed/sold 668,065 options to buy
@ $1.55, valued at
$1M
Disposed/sold 69,822 options to buy
@ $1.55, valued at
$108.2k
Disposed/sold 98,252 options to buy
@ $5.93, valued at
$582.6k
Disposed/sold 200,000 options to buy
@ $13.88, valued at
$2.8M
Disposed/sold 400,000 options to buy
@ $5.08, valued at
$2M
|
|
| 10/05/2021 |
3
| Edick Paul R (See Remarks) has filed a Form 3 on Xeris Biopharma Holdings, Inc. |
| 02/01/2021 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 225,000 shares
@ $0
Granted 400,000 options to buy
@ $5.08, valued at
$2M
|
|
| 12/10/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 10,000 shares
@ $4.0551, valued at
$40.6k
|
|
| 06/08/2020 |
4
| Edick Paul R (Director) has filed a Form 4 on Milestone Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $3.74, valued at
$56.1k
|
|
| 05/11/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 33,000 shares
@ $3, valued at
$99k
|
|
| 03/02/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 185,000 shares
@ $0 |
|
| 02/18/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 20,000 shares
@ $4.15, valued at
$83k
|
|
| 02/04/2020 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 9,801 shares
@ $6.37, valued at
$62.4k
|
|
| 11/27/2019 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 17,935 shares
@ $8.5466, valued at
$153.3k
|
|
| 05/29/2019 |
4
| Edick Paul R (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 6,154 restricted stock units
@ $0 |
|
| 05/08/2019 |
3
| Edick Paul R (Director) has filed a Form 3 on Milestone Pharmaceuticals Inc. |
| 03/12/2019 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Bought 30,000 shares
@ $9.1195, valued at
$273.6k
|
|
| 02/01/2019 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 125,000 shares
@ $0
Granted 200,000 options to buy
@ $13.88, valued at
$2.8M
|
|
| 08/27/2018 |
4
| Edick Paul R (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 500 shares
@ $10.4374, valued at
$5.2k
|
|
| 06/27/2018 |
4
| Edick Paul R (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Converted 13,430 shares
@ $0
Converted 23,922 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| Edick Paul R (See Remarks) has filed a Form 3 on XERIS PHARMACEUTICALS INC |
| 06/12/2018 |
4
| Edick Paul R (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 54,348 shares
@ $2.76, valued at
$150k
|
|
| 05/30/2018 |
4
| Edick Paul R (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 15,913 shares
@ $0
Converted 4,050 shares
@ $0
Converted 1,591 shares
@ $0
Converted 15,913 options to buy
@ $0
Converted 4,050 options to buy
@ $0
Converted 1,591 options to buy
@ $0 |
|
| 05/29/2018 |
4
| Edick Paul R (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 6,154 restricted stock units
@ $0 |
|
| 05/24/2018 |
3
| Edick Paul R (Director) has filed a Form 3 on Iterum Therapeutics plc |
| 02/13/2018 |
4
| Edick Paul R (Director) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 14,930 shares
@ $18, valued at
$268.7k
Disposed/sold 10,000 options to buy
@ $10.3, valued at
$103k
|
|
| 07/07/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|